CHF Solutions, Inc. (CHFS) Prices 1.22M Share Registered Direct Offering at $1.12/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/27/2026
- Wall Street stocks end tad lower after hot inflation data ahead of Nvidia earnings
- Nvidia forecasts 70% sales growth next year, signals AI spending boom has years left to run
- Oil settles down after choppy session as investors weigh Hormuz talks
- Meta to pay up to $16.68 billion in mass social media settlement
- Anthropic agrees to $45bn cloud computing deal with Nscale - report
- Nutanix (NTNX) Tops Q4 EPS by 11c, Beats in Revenue; Offers Q1 Revenue Guidance
- Boston Scientific discloses cybersecurity incident causing global disruption
- Crude Inventory Rose 0.1 Million Barrels Last Week - EIA
- FDA approves Revolution Medicines pancreatic cancer drug Rasonque
- NVIDIA (NVDA) Tops Q2 EPS by 14c, Offers Guidance
CHF Solutions, Inc. (CHFS) Misses Q3 EPS by 44c
November 5, 2019 8:07 AM ESTCHF Solutions, Inc. (NASDAQ: CHFS) reported Q3 EPS of ($1.70), $0.44 worse than the analyst estimate of ($1.26). Revenue for the quarter came in at $1.25 million versus the consensus estimate of $1.3 million.
Submitted 510(k) application for pediatric label modification on September 30, 2019. Expect regulatory clearance early Q1 2020.Announced publication of a multi-center, retrospective clinical study titled Kidney Support in Children Using an Ultrafiltration Device in the Clinical Journal of the American Society of Nephrology, highlighting the use of Aquadex FlexFlow®... More